{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:22:03Z","timestamp":1789399323433,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T00:00:00Z","timestamp":1355356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T00:00:00Z","timestamp":1355356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/jhh.2012.61","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T10:31:30Z","timestamp":1355394690000},"page":"412-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey"],"prefix":"10.1038","volume":"27","author":[{"given":"S","family":"Perlini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Naditch-Brule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Farsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zidek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,13]]},"reference":[{"issue":"6","key":"BFjhh201261_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/oxfordjournals.aje.a113046","volume":"112","author":"AR Dyer","year":"1980","unstructured":"Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112 (6): 736\u2013749.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"BFjhh201261_CR2","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","volume":"113","author":"WB Kannel","year":"1987","unstructured":"Kannel WB, Kannel C, Paffenbarger RS, Cupples LA . Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113 (6): 1489\u20131494.","journal-title":"Am Heart J"},{"issue":"4","key":"BFjhh201261_CR3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","volume":"125","author":"MW Gillman","year":"1993","unstructured":"Gillman MW, Kannel WB, Belanger A, D\u2019Agostino RB . Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125 (4): 1148\u20131154.","journal-title":"Am Heart J"},{"issue":"10","key":"BFjhh201261_CR4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","volume":"26","author":"A Diaz","year":"2005","unstructured":"Diaz A, Bourassa MG, Guertin MC, Tardif JC . Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26 (10): 967\u2013974.","journal-title":"Eur Heart J"},{"issue":"10","key":"BFjhh201261_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/eurheartj\/ehi235","volume":"26","author":"P Palatini","year":"2005","unstructured":"Palatini P . Heart rate: a strong predictor of mortality in subjects with coronary artery disease. Eur Heart J 2005; 26 (10): 943\u2013945.","journal-title":"Eur Heart J"},{"issue":"3","key":"BFjhh201261_CR6","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/01.hjh.0000229464.09610.ff","volume":"24","author":"S Laurent","year":"2006","unstructured":"Laurent S, Tropeano AI, Boutouyrie P . Pulse pressure reduction and cardiovascular protection. J Hypertens Suppl 2006; 24 (3): S13\u2013S18.","journal-title":"J Hypertens Suppl"},{"issue":"1","key":"BFjhh201261_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacc.2005.08.052","volume":"47","author":"ME Safar","year":"2006","unstructured":"Safar ME, Thomas F, Blacher J, Nzietchueng R, Bureau JM, Pannier B et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 2006; 47 (1): 72\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"BFjhh201261_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11906-000-0008-0","volume":"2","author":"SS Franklin","year":"2000","unstructured":"Franklin SS . Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance? Curr Hypertens Rep 2000; 2 (3): 253\u2013259.","journal-title":"Curr Hypertens Rep"},{"issue":"7","key":"BFjhh201261_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/HJH.0b013e3280fa83a6","volume":"25","author":"M Volpe","year":"2007","unstructured":"Volpe M, Tocci G, Trimarco B, Agabiti-Rosei E, Borghi C, Ambrosioni E et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25 (7): 1491\u20131498.","journal-title":"J Hypertens"},{"issue":"2","key":"BFjhh201261_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archinte.167.2.141","volume":"167","author":"YR Wang","year":"2007","unstructured":"Wang YR, Alexander GC, Stafford RS . Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 2007; 167 (2): 141\u2013147.","journal-title":"Arch Intern Med"},{"issue":"1","key":"BFjhh201261_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1161\/01.HYP.0000103630.72812.10","volume":"43","author":"K Wolf-Maier","year":"2004","unstructured":"Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43 (1): 10\u201317.","journal-title":"Hypertension"},{"issue":"6","key":"BFjhh201261_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, German\u00f2 G et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25 (6): 1105\u20131187.","journal-title":"J Hypertens"},{"issue":"10","key":"BFjhh201261_CR13","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1097\/HJH.0b013e32830c45c3","volume":"26","author":"SE Kjeldsen","year":"2008","unstructured":"Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C . Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens 2008; 26 (10): 2064\u20132070.","journal-title":"J Hypertens"},{"key":"BFjhh201261_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1475-2840-8-51","volume":"8","author":"W Zidek","year":"2009","unstructured":"Zidek W, Naditch-Brule L, Perlini S, Farsang C, Kjeldsen SE . Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovasc Diabetol 2009; 8: 51.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"BFjhh201261_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2007.09.033","volume":"199","author":"AC Vergnaud","year":"2008","unstructured":"Vergnaud AC, Protogerou AD, Li Y, Czernichow S, Vesin C, Blacher J et al. Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate. Atherosclerosis 2008; 199 (1): 222\u2013229.","journal-title":"Atherosclerosis"},{"issue":"2","key":"BFjhh201261_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1559-4564.2007.06006.x","volume":"2","author":"G Mul\u00e8","year":"2007","unstructured":"Mul\u00e8 G, Nardi E, Cottone S, Cusimano P, Palermo A, Incalcaterra F et al. Impact of the metabolic syndrome on total arterial compliance in essential hypertension patients. J Cardiometab Syndr 2007; 2 (2): 84\u201390.","journal-title":"J Cardiometab Syndr"},{"issue":"2","key":"BFjhh201261_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.amjhyper.2006.06.014","volume":"20","author":"AD Protogerou","year":"2007","unstructured":"Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME . Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 2007; 20 (2): 127\u2013133.","journal-title":"Am J Hypertens"},{"issue":"6","key":"BFjhh201261_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","volume":"21","author":"European Society of Hypertension-European Society of Cardiology Guidelines Committee","year":"2003","unstructured":"European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21 (6): 1011\u20131053.","journal-title":"J Hypertens"},{"issue":"5","key":"BFjhh201261_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/jhh.2008.136","volume":"23","author":"C Farsang","year":"2009","unstructured":"Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE . Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. J Hum Hypertens 2009; 23 (5): 316\u2013324.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"BFjhh201261_CR20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.crd.0000380842.14048.7e","volume":"13","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005; 13 (6): 322\u2013327.","journal-title":"Cardiol Rev"},{"issue":"24","key":"BFjhh201261_CR21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jacc.2007.08.043","volume":"50","author":"GM De Ferrari","year":"2007","unstructured":"De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ . Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50 (24): 2285\u20132290.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh201261_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1749-6632.2001.tb03701.x","volume":"940","author":"JS Floras","year":"2001","unstructured":"Floras JS . Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure. Ann NY Acad Sci 2001; 940: 500\u2013513.","journal-title":"Ann NY Acad Sci"},{"issue":"9","key":"BFjhh201261_CR23","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/HJH.0b013e32833c2088","volume":"28","author":"A Radaelli","year":"2010","unstructured":"Radaelli A, Castiglioni P, Balestri G, Cesana F, De Carlini C, Soriano F et al. Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure. J Hypertens 2010; 28 (9): 1908\u20131912.","journal-title":"J Hypertens"},{"issue":"10","key":"BFjhh201261_CR24","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2003.12.049","volume":"43","author":"G Schillaci","year":"2004","unstructured":"Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43 (10): 1817\u20131822.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"BFjhh201261_CR25","first-page":"423","volume":"23","author":"A Vazquez Vigoa","year":"2003","unstructured":"Vazquez Vigoa A, Vazquez Cruz A, Calderin RO, Buchaca EF, Cruz Alvarez NM, Jimenez Paneque R et al. [Metabolic syndrome in patients with essential hypertension]. Nefrologia 2003; 23 (5): 423\u2013431.","journal-title":"Nefrologia"},{"issue":"1","key":"BFjhh201261_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/08037050701217817","volume":"16","author":"J Navarro","year":"2007","unstructured":"Navarro J, Redon J, Cea-Calvo L, Lozano JV, Fernandez-Perez C, Bonet A et al. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press 2007; 16 (1): 20\u201327.","journal-title":"Blood Press"},{"issue":"2","key":"BFjhh201261_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0953-6205(03)00022-0","volume":"14","author":"JF Ascaso","year":"2003","unstructured":"Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R . Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med 2003; 14 (2): 101\u2013106.","journal-title":"Eur J Intern Med"},{"issue":"10","key":"BFjhh201261_CR28","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1097\/00004872-200410000-00023","volume":"22","author":"C Cuspidi","year":"2004","unstructured":"Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22 (10): 1991\u20131998.","journal-title":"J Hypertens"},{"issue":"5","key":"BFjhh201261_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2796.2005.01468.x","volume":"257","author":"G Leoncini","year":"2005","unstructured":"Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi D, Parodi A et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 2005; 257 (5): 454\u2013460.","journal-title":"J Intern Med"},{"issue":"6","key":"BFjhh201261_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2796.2005.01493.x","volume":"257","author":"G Mul\u00e8","year":"2005","unstructured":"Mul\u00e8 G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257 (6): 503\u2013513.","journal-title":"J Intern Med"},{"issue":"3","key":"BFjhh201261_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.HYP.0000255983.32896.b9","volume":"49","author":"G Grassi","year":"2007","unstructured":"Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell\u2019Oro R, Bolla G et al. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 2007; 49 (3): 535\u2013541.","journal-title":"Hypertension"},{"issue":"2","key":"BFjhh201261_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ajh.2008.331","volume":"22","author":"Y Shigetoh","year":"2009","unstructured":"Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22 (2): 151\u2013155.","journal-title":"Am J Hypertens"},{"issue":"21","key":"BFjhh201261_CR33","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","volume":"288","author":"HM Lakka","year":"2002","unstructured":"Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288 (21): 2709\u20132716.","journal-title":"JAMA"},{"issue":"1","key":"BFjhh201261_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0002-8703(03)00442-3","volume":"147","author":"DB Panagiotakos","year":"2004","unstructured":"Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 2004; 147 (1): 106\u2013112.","journal-title":"Am Heart J"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201261","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T15:44:15Z","timestamp":1647531855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,13]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFjhh201261"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2012.61","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,13]]},"assertion":[{"value":"24 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Naditch-Br\u00fbl\u00e9 declares to be an employee of Sanofi-Aventis. All other authors have attended advisory boards and have held lectures for a number of pharmaceutical companies including the sponsor.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}